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Abstract
Background: Cancer is a leading cause of morbidity and mortality worldwide with a majority of cases and deaths
occurring in developing countries. While cancer of the lung, breast, colorectum, stomach and prostate are the
most common types of cancer globally, in east and southern Africa these are less common and comprehensive
data to inform policies are lacking.
Methods: Nationwide cancer registry was conducted between September and October 2010 in Malawi. New
cancer cases registered from 2007 to 2010 were identified from hospital and clinic registers of 81 out of 84 health
facilities providing cancer diagnosis, treatment or palliative care services. Demographic and cancer data were
extracted from registers and case notes using a standard form.
Results: A total of 18,946 new cases of cancer were registered in Malawi from 2007-2010. Of these 55.9% were
females, 7.2% were children aged less than 15 years, 76.5% were adults aged 15-59 years and 16.4% were elderly
aged 60 years or more. Only 17.9% of the cases had histologically verified diagnosis, 33.2% were diagnosed
clinically and 49.6% based on clinical and some investigations. Amongst females, cancer of the cervix was the
commonest accounting for 45.4% of all cases followed by Kaposi sarcoma (21.1%), cancer of the oesophagus
(8.2%), breast (4.6%) and non-Hodgkin lymphoma (4.1%). In males, Kaposi sarcoma was the most frequent (50.7%)
then cancer of oesophagus (16.9%), non-Hodgkin lymphoma (7.8), prostate (4.0%) and urinary bladder (3.7%). Age-
standardised incidence rate per 100,000 population for all types of cancer in males increased from 31 in 1999-2002
to 56 in 2007-2010. In females it increased from 29 to 69. Kaposi sarcoma and cancer of the oesophagus, cervical
cancer and Kaposi sarcoma were the main causes for the increased incidence in males and females respectively. It
was estimated that, annually at least 8,151 new cases of cancer (all types) occur in Malawi.
Conclusions: This study provided data on common types and trends of cancer that could be used to focus
prevention, treatment and control interventions in the context of limited resources. The problem of under-
reporting and misdiagnosis of cancer cases has been highlighted.
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Background
Cancer is a leading cause of morbidity and mortality
worldwide. In 2008, globally, there were 12.7 million new
cancer cases and 7.6 million cancer deaths (around 13% of
all deaths) with 56% of the new cases and 63% of the
cancer deaths occurring in developing countries. It is
projected that by 2030, the number of new cancer cases
and deaths will increase by 69% and 72% to 21.4 million
and 13.2 million respectively [1,2]. While cancer of the
lung (12.7%), breast (10.9%), colorectum (9.7%), stomach
(7.8%) and prostate (7.2%) are the most common types of
cancer globally [1,2], in sub-Saharan Africa (SSA) these
are less common. In eastern and southern Africa (ESA)
where HIV prevalence is high, AIDS-defining cancers
including Kaposi sarcoma, cervical cancer, and
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Africa, cancer of the liver is the most common [3-6].
Prevalences of risk factors for cancer in ESA are high; HIV
10% or more, human papillomavirus 34%, tobacco smok-
ing and harmful use of alcohol particularly in men 25%
and 19% respectively and overweight in women 28% or
more [7-9]. Indoor smoke from household use of solid
fuels and urban air pollution are other common cancer
risk factors in this region [10]. Comprehensive data on the
burden and trends of cancer to inform policies, strategies
and interventions are lacking in most countries in eastern
and southern African region. Between September and
October 2010, a nationwide cancer registry was conducted
to determine the magnitude, trends of cancer and its chal-
lenges in Malawi.
Methods
Survey design, sites and data collection
Malawi Cancer Registry was established in 1985 as a
population-based cancer registry with the aim of main-
taining high quality cancer surveillance system and pro-
moting research on cancer through collaboration.
Utilising the cancer registry system, a cross-sectional
health facility-based nationwide survey was conducted.
All district (secondary), central (tertiary) and main public
and private hospitals providing cancer laboratory diagno-
sis, treatment, palliative care or referral services were
eligible and mapped out as survey sites. A total of 84 (70
public, 6 private, 6 research and 2 non-governmental)
facilities met the criteria. Of these, 81 (94.4%) consented
to take part and data were collected. Three facilities (all
international research institutions) refused to take part.
The reason for their refusal was that they needed clear-
ance from their headquarters which was not granted. The
other three research institutions were local and partici-
pated in this study. Cancer cases and deaths were identi-
fied from registers in outpatient department (OPD),
inpatient wards (all wards available at the facility), clinics
(all clinics available), laboratory, pharmacy, theatre and
mortuary. Demographic and cancer data on the identified
cancer cases or deaths were extracted using a standard
form from Malawi Cancer Registry. Data were extracted
for period 1 January 2007 to 31 August 2010. Data collec-
tion was conducted by trained health workers (nurses
and clinical officers) from September to October 2010.
Data management
Data were entered, cleaned and analysed using World
Health Organisation cancer registry software version 4
(Can Reg4). The software had ability to detect duplicates
thereby reducing the risk of double counting of cases
that might have visited several hospitals or same hospital
at different times. It also had the ability to estimate the
age-standardised incidence rates based on age-specific
national population data. National population data disag-
gregated by 5-year age groups and by sex was obtained
from the Malawi National Statistics Office (NSO). The
NSO data were entered and used to produce age-standar-
dised incidence rates in Can Reg4. The existing data in
the Malawi Cancer Registry database were used to pro-
duce trends of cancer from 1987-2010.
Ethics statement
Ethical approval was granted by the Malawi National
Health Sciences Research and Ethics Committee. Written
informed consent to extract data from hospital registers
and records was obtained from directors of hospitals that
participated in the study.
Results
Characteristics of new cases of cancer and methods of
diagnosis
For the period 1 January 2007 to 31 August 2010, a total
of 18,946 new cases of cancer were registered in 81 out
of 84 main health facilities (public, non-governmental
organisations, and private) in Malawi. Of these new
cases, 55.9% were females, 7.2% were children aged less
than 15 years, 76.5% were adults aged 15-59 years and
16.4% were aged 60 years or more. Geographically, 13.4%
of the new cases were from the northern, 35.0% from
central and 51.6% from southern region. By diagnosis,
only 17.9% of the new cases were diagnosed based on his-
tology, cytology or haematology laboratory findings,
33.2% were diagnosed clinically (based on history taking
and physical examination) and 49.6% based on clinical
and some investigations (radiology, screening tests such
as prostate specific antigen test, cervical cancer screening
using visual inspection with acetic acid). Only 137 (0.7%)
out of 18,946 cases had information on the stage of can-
cer at the time of diagnosis. Table 1 below shows number
of registered new cases, method of diagnosis and geogra-
phical distribution of registered cancer cases in Malawi
from 1987-2010.
Common types of cancer in Malawi
Of the 10,541 new cancer cases among females registered
between 2007 and 2010, cancer of the cervix was the com-
monest accounting for 45.4% of all cases followed by
Kaposi sarcoma (21.1%), cancer of the oesophagus (8.2%),
breast (4.6%) and non-Hodgkin lymphoma (4.1%). In
males, of the 8,314 new cases registered in the same per-
iod, Kaposi sarcoma was the commonest (50.7%) followed
by cancer of oesophagus (16.9%), non-Hodgkin lymphoma
(7.8%), prostate (4.0%) and urinary bladder (3.7%). In both
sexes (sample size 18,855), the top five common cancers
were; Kaposi sarcoma (34.1%), cancer of the cervix
(25.4%), oesophagus (12.0%), non-Hodgkin lymphoma
(5.7%) and urinary bladder (2.9%). Lung cancer was one of
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in both sexes, 0.2% and 0.1% in males and females respec-
tively. In children under 15 years of age, of the 1,280 regis-
tered new cases, non-Hodgkin lymphoma (mainly
Burkitt’s) was the commonest accounting for 56.4%
followed by Kaposi sarcoma (15.0%), cancer of the eye
(7.3%), kidney (4.5%) and bone (2.2%). Of the 13,660 regis-
tered new cancer cases aged 15-59 years (both sexes),
41.3% had Kaposi sarcoma, 28.3% had cervical cancer,
9.4% had cancer of the oesophagus, 2.6% breast and 2.6%
had eye cancer. In the elderly (age 60 years or more), com-
mon cancers were; oesophagus (28.7%), cervix (24.0%),
Kaposi sarcoma (10.0%) and prostate (7.7%). Table 2 sum-
marises the common types of cancer by gender and age.
Age-standardised incidence
In males, age-standardised incidence rate (ASR) per
100,000 population per year was estimated at 55.5 while in
females was 68.8 for all types of cancer. Kaposi sarcoma,
cancer of the oesophagus, prostate, non-Hodgkin and
urinary bladder were the top five cancers in males with
ASR of 25.4, 12.4, 3.3, 2.5 and 2.5 respectively. In females,
cancer of the cervix, Kaposi sarcoma, cancer of the oeso-
phagus, breast and non-Hodgkin lymphoma were the top
five with ASR of 33.6, 11.9, 6.8, 3.5 and 1.7 respectively.
Based on these estimated ASR and age, sex disaggregated
national population data from national statistical office, it
was estimated that annually, there were at least 8,151 new
cases of cancer (all types); 2,408 Kaposi sarcoma, 1,236
cervical cancer, 549 oesophageal cancer, 273 non-Hodgkin
lymphoma, and 273 urinary bladder cancer cases in
Malawi (Table 3, Figure 1 and Figure 2).
Trends of age-standardised incidence
Age-standardised incidence of cancer per 100,000 popu-
lation per year (all types) in males increased from 31.0 in
1999-2002 to 51.4 in 2003-2006 to 55.5 in 2007-2010.
Kaposi sarcoma and cancer of the oesophagus had the
highest increase in ASR which increased from 10.9 to
18.2 to 25.3; 5.5 to 11.1 to 12.4 respectively. In females,
ASR increased from 28.8 to 50.5 to 68.8 for all types of
cancer with the major increase in cervical cancer and
Kaposi sarcoma of 9.8 to 19.6 to 33.6; 5.1 to 8.5 to 11.9
respectively (Figure 3 and Figure 4).
Discussion
This national cancer registry study demonstrated that can-
cer is an important public health problem and incidence
was increasing in Malawi. Kaposi sarcoma, cancer of the
cervix and cancer of the oesophagus were the major cause
of the increasing trend. With high HIV prevalence of
10.6% [11], the increase is Kaposi sarcoma and cervical
cancer was in agreement with the findings from other stu-
dies [12,13]. The active case finding was more extensive in
this survey providing more complete national data than
previously reported.
The introduction and scaling up of free HIV antiretro-
viral therapy (ART) programme and insecticide-treated
bednets (ITN) in 2003 did not seem to have an impact on
the trends of Kaposi sarcoma, cervical cancer and Burkitt’s
lymphoma respectively as suggested by studies from other
countries [13,14]. This could suggest that higher ART and
ITN coverages are required to show impact on HIV and
malaria related cancers than the current (2010) 65% cover-
age of estimated population in need of ART and 40%
Table 1 Number of registered new cases, method of diagnosis and geographical distribution of cancer in Malawi:
1987-2010
1987-1990 1991-1994 1995-1998 1999-2002 2003-2006 2007-2010
n% n% n% n% n % n %
New registered cancer cases:
Males 2,335 46.4 2,276 49.5 2,576 51.3 3,983 50.5 6,850 49.8 8,360 44.1
Females 2,699 53.6 2,326 50.5 2,447 48.7 3,901 49.5 6,914 50.2 10,586 55.9
Total 5,034 100.0 4,602 100.0 5,023 100.0 7,884 100.0 13,764 100.0 18,946 100.0
Method of cancer diagnosis:
Clinical only 0 0 405 8.8 924 18.4 2562 32.5 4515 32.8 6101 32.2
Clinical and some investigations 1 0.01 341 7.4 1000 19.9 2278 28.9 5602 40.7 9397 49.6
Histology/haematology/cytology 5033 99.9 3856 83.8 3099 61.7 3043 38.6 3647 26.5 3448 18.2
Total 5034 100.0 4602 100.0 5023 100.0 7884 100.0 13764 100.0 18946 100.0
Cancer cases by region:
Northern 35 6.8 433 9.4 312 6.2 603 7.7 880 6.4 2538 13.4
Central 137 26.6 1,261 27.4 1,006 20.0 1,347 17.2 3,478 25.3 6,630 35.0
Southern 343 66.6 2,909 63.2 3,711 73.8 5,883 75.1 9,389 68.3 9,775 51.6
Total 515 100.0 4,603 100.0 5,029 100.0 7,833 100.0 13,747 100.0 18,944 100.0
n = number of registered new cancer cases,% = percentage
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five years [11,15]. For cancer of the oesophagus, it was not
known why the trend was increasing. High HIV preva-
lence was less likely because the association between
cancer of the oesophagus and HIV/AIDS is not well
established although both may be related to fumonisin, a
mycotoxin found in maize [16]. Increase in smoking, con-
sumption of alcohol and maize contaminated with fumo-
nisin could be some of the factors contributing to the
increase in incidence of oesophageal cancer [7,16,17].
Table 2 Common types of registered new cancer cases by gender and age in Malawi: 2007-2010






% (n) % (n) % (n) % (n) % (n) % (n)
Lung 0.2 (19) 0.1 (14) 0.2 (33) - - 0.1 (19) 0.3 (10)
Breast 0.3 (26) 4.6 (480) 2.7 (506) - - 2.6 (357) 3.7 (109)
Kidney 0.4 (34) 0.4 (41) 0.4 (75) 4.5 (58) 0.1 (13) 0.2 (6)
Penis 1.4 (117) - - 0.6 (117) - - 0.6 (80) 0.9 (26)
Liver 1.5 (121) 0.7 (70) 1.0 (191) 1.5 (19) 0.9 (124) 1.2 (36)
Ovary - - 0.9 (99) 0.5 (99) - - 0.5 (72) 0.5 (15)
Bone 1.6 (129) 1.2 (123) 1.3 (252) 2.2 (28) 1.3 (174) 1.0 (29)
Stomach, intestine, rectum, anus 1.8 (147) 1.4 (152) 1.6 (299) - - 1.3 (179) 4.1 (121)
Eye 2.7 (225) 2.5 (266) 2.6 (491) 7.3 (94) 2.6 (352) 1.0 (30)
Urinary bladder 3.7 (308) 2.2 (232) 2.9 (540) 0.5 (7) 2.2 (300) 5.1 (149)
Prostate 4.0 (332) - - 1.8 (332) - - 0.5 (70) 7.7 (226)
Non-Hodgkin lymphoma 7.8 (649) 4.1 (427) 5.7 (1,076) 56.4 (722) 2.1 (289) 1.3 (37)
Oesophagus 16.9 (1,406) 8.2 (862) 12.0 (2,268) - - 9.4 (1,286) 28.7 (838)
Cervix - - 45.4 (4,787) 25.4 (4,787) - - 28.3 (3,869) 24.0 (701)
Kaposi sarcoma 50.7 (4,213) 21.1 (2,225) 34.1 (6,438) 15.0 (192) 41.3 (5,642) 10.0 (291)
Others 7.1 (588) 7.2 (763) 7.2 (1,351) 12.5 (160) 6.1 (834) 10.2 (297)
Total 100.0 (8,314) 100.0 (10,541) 100.0 (18,855) 100.0 (1,280) 100.0 13,660 100.0 (2,921)
n = number of cancer cases in the group,% = percentage
Table 3 Age-standardised incidence rate and estimated annual number of registered new cancer cases by gender in
Malawi
Age standardised cancer
incidence rate per 100,000
population per year
Estimated annual
number of new cancer
cases
Estimated total annual number of new cancer cases
Males Females Males Females
Lung 0.2 0.1 4 2 6
Penis 0.9 - 31 - 31
Liver 0.8 0.4 51 27 78
Ovary - 0.6 - 40 40
Bone 0.7 0.7 45 47 92
Stomach, intestine, rectum, anus 0.7 1.2 19 36 55
Eye 1.3 1.4 83 94 177
Urinary bladder 2.5 1.7 159 114 273
Prostate 3.3 - 73 - 73
Non-Hodgkin lymphoma 2.5 1.7 159 114 273
Breast - 3.5 - 106 106
Oesophagus 12.4 6.8 343 206 549
Kaposi sarcoma 25.4 11.9 1,609 799 2,408
Cervix - 33.6 - 1,236 1,236
All types 55.5 68.8 3,529 4,622 8,151
Msyamboza et al. BMC Research Notes 2012, 5:149
http://www.biomedcentral.com/1756-0500/5/149
Page 4 of 8Lung cancer, the world’s most frequent cancer in males, is
generally reported to be less common in sub-Saharan
Africa [3,18,19] although tobacco smoking is common
with prevalence of at least 25% in men [7]. The reasons
for relatively low prevalence of lung cancer in the presence
of high prevalence of tobacco smoking in sub-Saharan
Africa are unknown. Under-reporting, misdiagnosis, com-
peting high levels of HIV/AIDS related cancers could be
the possible explanations [18,20,21].
Our findings on the significance of gender and age
differences for Kaposi sarcoma, cancer of oesophagus
and non-Hodgkin lymphoma being more common in
males than females, cancer of the oesophagus in people
aged 60 years or more, and Kaposi sarcoma and non-
Hodgkin lymphoma, in particular Burkitt’s, being the
most common cancers in children under 15 years of
age were consistent with other studies [22-25]. Two
thirds (67.1%) of non-Hodgkin lymphoma cases were
children aged less than 15 years old. As countries in
sub-Saharan Africa implement universal coverage of
ART and ITNs, there would be need to monitor the
trends of HIV and malaria related cancers as one way
of assessing other public health benefits of these
interventions.
Figure 1 Cancer age-standardised incidence rate in males in Malawi: 2007-2010.
Figure 2 Cancer age-standardised incidence rate in females in Malawi: 2007-2010.
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Reproductive Health Unit, implemented a screen-and-
treat programme for cervical cancer using visual inspec-
tion with acetic acid (VIA) approach. The programme
started in 2004 and targeted women aged 30-50 years old.
As of June 2011, there were a total of 81 health facilities
providing cervical cancer services (50 VIA only, 29 VIA
and cryotherapy and 2 VIA, cryotherapy, loop electrosur-
gical excision procedure (LEEP) and major surgery).
Cumulatively, a total of 59,217 women were screened,
5,744 (9.7%) were VIA positive and 1,777 (3.0%) had sus-
pected cervical cancer [26]. This study demonstrated that
12.0% and 32.1% of cervical cancer cases were aged 20-29
years and 50 years or more respectively. This would sug-
gest that the VIA Programme in Malawi could be missing
at least 44% of women with cervical cancer. Data on popu-
lation-based, age-specific prevalence of Human papilloma-
virus (HPV), the virus that causes cervical cancer is not
available in Malawi. However, WHO estimates that the
overall HPV prevalence is about 34% [27]. Studies from
other countries reported HPV prevalence in women hav-
ing two peaks, one at 15-29 year age group and the other
at 60-69 year age group [28,29]. This, together with high
HIV prevalence could be some of the reasons for cervical
Figure 3 Trends in cancer incidence in males in Malawi: 1999-2010.
Figure 4 Trends in cancer incidence in females in Malawi: 1999-2010.
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cancer screening is the only established public health
cancer screening programme in Malawi. Breast (mammo-
graphy) and prostate (prostate-specific antigen test and
digital rectal examination) cancer screening were available
in only one private hospital. This private hospital partici-
pated in the study. Lung cancer was not routinely
screened. Introduction of other cancer screening services
in addition to cervical cancer in public health facilities
could enhance early detection and treatment.
This study also revealed that only 18% of the cancer
cases had laboratory verified diagnosis. Inadequate labora-
tory capacity (only one public and one private histology
laboratory, all in Blantyre), long waiting time to get histol-
ogy results, confidence of health workers in diagnosing
some cancers clinically, in particular Kaposi sarcoma (the
commonest cancer), late presentation of patients to health
facility and lack of treatment, in particular, chemotherapy
and radiotherapy could be some of the factors leading to
low laboratory verified diagnosis. The low level of labora-
tory verified cases would suggest that the reported number
of cancer cases was likely to be under-estimated because
of under diagnosis and missing of cancer cases [21]. Cur-
rent WHO estimates suggest that every year there are at
least 2,316 new cases of cervical cancer cases in Malawi
[27] while estimate from this study was 1,236. This illu-
strated that the reported number of registered new cervi-
cal cancer cases was only 53% of the actual problem at the
community level. Some of the possible reasons for under-
detection of cervical cancer cases could be low coverage of
the screening programme (3.7% of the target group) and
low specificity of VIA although it is the cost-effective
screening method recommended for resource-limited set-
tings and is comparable to Pap smear [27,30-32]. Despite
the under-reporting, population-based cancer registry is
the cost-effective method of collecting comprehensive data
on cancer that resource-poor countries in sub-Saharan
Africa are being encouraged to establish [33].
About half (52%) of registered new cancer cases (all
types of cancer) were from the southern region with
central and northern region accounting for 35% and
13% respectively. Population distribution was less likely
to be the main reason as distribution was similar in the
south and centre at 45% and 42% respectively [34]. The
extent of active case finding in this survey was similar in
all the regions whereby as many health facilities as pos-
sible were visited. Availability of diagnostic services
hence less specimen transport cost and waiting time for
results, cancer registry office and high HIV prevalence
(south 18%, centre 10%, and north 8%) in the southern
region were likely to be some of the contributing factors
[11].
Data on lifestyles (tobacco smoking and alcohol con-
sumption) and HIV status were not available. Some of
the registers, particularly in public facilities were miss-
ing. These were the limitations of this study. These lim-
itations apply to all studies that utilise available health
facility data in general. Another limitation of this study
was the refusal by three international research institu-
tions to participate in this study. The reason for their
refusal was that they had to seek clearance from their
headquarters which was not granted. However, all the
three international research institutions were housed
within the public hospital and were recruiting cases
from outpatient department or wards. In addition, all
the institutions sent specimens to National Histopathol-
ogy Laboratory which participated in this study. It was
therefore less likely that non-participation of these three
international research institutions had significant effect
on the results as most of cases were likely to be cap-
tured either from public hospital registers where cases
were first registered or from histology laboratory where
specimens were sent or both. The use of clinical diagno-
sis only, cancer screening tests such as VIA and prostate
specific antigen (PSA) have their own limitations but
these limitations were beyond this study. This study
only collected and analysed data that were already there.
Nevertheless, the comprehensive analysis of the burden
of cancer and its challenges demonstrated by this study
provided local evidence that could be used to inform
policies, strategies and interventions for prevention and
control of cancer in Malawi, eastern and southern Afri-
can region.
Conclusion
Cancer is a public health problem and the trend is
increasing in Malawi, a poor country in eastern and
southern Africa. Scaling up and/or improving the quality
of cervical and breast cancer screening programmes,
laboratory verified diagnosis, chemotherapy and radio-
therapy treatment and introduction of human papillo-
mavirus vaccine for cervical cancer control could be
some of cancer prevention, treatment and control inter-
ventions that Malawi and other countries in eastern and
southern Africa may consider to strengthen or adopt.
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